Phase II Study of Neoadjuvant Chemotherapy With Doxorubicin Followed by Docetaxel-Cisplatin in Locally Advanced Breast Cancer
NCT00538525
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
10
Enrollment
OTHER
Sponsor class
Conditions
Breast Cancer
Interventions
DRUG:
Doxorubicin, Docetaxel, Cisplatin
Sponsor
King Faisal Specialist Hospital & Research Center